One of the many changes to the way IPOs are sold in Australia is the way equities research analysts, the ones who truly know their patch and who fund managers trust, have been sidelined by harsher regulation.The analysts are supposed to be independent, can be a bit unpredictable, and their investment banker colleagues, paid millions to get a deal done for a listing company and/or its owner, can’t always trust their research team’s analyst to be on team IPO.Subscribe to gift this articleGift 5 articles to anyone you choose each month when you subscribe.Subscribe nowAlready a subscriber? Fetching latest articles
ASIC’s diet rulebook leaves equity analysts out in the cold
Ringing the ASX bell is easy. Keeping buyers on the hook is where research matters.
100 words~1 min read
